The CGPDTM has invited comments on new draft guidelines aimed at streamlining patent application procedures for pharmaceutical and biotechnology inventions.
CGPDTM Releases New Draft Guidelines for Pharma and Biotech Patents
The Controller General of Patents, Designs and Trademarks (CGPDTM) has issued new draft guidelines for the examination of patent applications pertaining to pharmaceutical and biotechnology inventions. These guidelines are intended to enhance the efficiency and clarity of the patent application process.
The CGPDTM is actively seeking feedback from stakeholders, underscoring the importance of collaborative input in refining these guidelines. The suggested changes aim to address existing challenges faced by patent applicants in these sectors, particularly in terms of compliance and procedural requirements.
Legal practitioners should engage with these guidelines to ensure that their patent applications align with the new directives, thereby optimizing their chances of compliance and approval in an evolving legal landscape.
Citations
- CGPDTM New Guidelines (2026)
